AUTISM IN REVIEW

J Med Liban. 2016 Aug;64(2):110-115.

Abstract

Autism spectrum disorders are a group of neurodevelopmental disorders characterized by impaired verbal and/or nonverbal communication in addition to repeti- tive stereotypical behaviors. We present a review article on this topic. Criteria for diagnosis are defined by the Diagnos- tic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5). Abnormalities at the level of synapses, including newly described genetic perturbations, have been implicated in the pathogenesis of autism. Non-invasive modalities like Diffusion Tensor Magnetic Resonance Imaging have identi- fied white matter tract involvemeht in the brains of autistic in- dividuals. Early and intensive intervention impact prognosis. Risperidone and aripiprazole are FDA approved for irritability in autism although no known medication relieves core symp- toms of social and communication impairment. Fluoxetine is used to decrease anxiety in autistic patients.

Publication types

  • Review

MeSH terms

  • Aripiprazole / therapeutic use
  • Autism Spectrum Disorder / diagnosis*
  • Autism Spectrum Disorder / drug therapy*
  • Central Nervous System Agents / therapeutic use
  • Diagnostic and Statistical Manual of Mental Disorders
  • Diffusion Tensor Imaging
  • Fluoxetine / therapeutic use
  • Humans
  • Risk Factors
  • Risperidone / therapeutic use
  • White Matter / diagnostic imaging

Substances

  • Central Nervous System Agents
  • Fluoxetine
  • Aripiprazole
  • Risperidone